HCSG - Glancy Prongay & Murray LLP Announces Investigation on Behalf of Healthcare Services Group Inc. Investors

Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Healthcare Services Group, Inc. investors (“Healthcare Services” or the “Company”) (NASDAQ: HCSG) concerning the Company and its officers’ possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com.

On March 4, 2019, the Company disclosed that the Securities and Exchange Commission (“SEC”) had sent a letter in November 2017 and a subpoena in March 2018 regarding the Company’s earnings per share calculation practices. Additionally, during the fourth quarter of 2018, the Company began an internal investigation into the matters related to the SEC subpoena. As a result, the Company would not be able to timely file its annual report for the period ended December 31, 2018. On this news, the Company’s share price fell $4.96 per share, or more than 13%, to close at $32.78 per share on March 4, 2019, thereby injuring investors.

If you purchased Healthcare Services securities, have information, or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, CA 90067 at 310-201-9150, Toll-Free at 888-773-9224, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number, and the number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190308005530/en/